.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Covington
Express Scripts
Boehringer Ingelheim
Cerilliant
Novartis
Chubb
Moodys
UBS
Citi

Generated: July 21, 2017

DrugPatentWatch Database Preview

NYDRAZID Drug Profile

« Back to Dashboard

Which patents cover Nydrazid, and when can generic versions of Nydrazid launch?

Nydrazid is a drug marketed by Sandoz and Bristol Myers Squibb and is included in two NDAs.

The generic ingredient in NYDRAZID is isoniazid. There are five drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the isoniazid profile page.

Summary for Tradename: NYDRAZID

Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: see list87
Clinical Trials: see list1
Patent Applications: see list8,056
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NYDRAZID at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
NYDRAZID
isoniazid
INJECTABLE;INJECTION008662-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Bristol Myers Squibb
NYDRAZID
isoniazid
TABLET;ORAL008392-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Fuji
Healthtrust
Cipla
Queensland Health
Teva
Chinese Patent Office
McKinsey
Fish and Richardson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot